NCT07208253View on ClinicalTrials.gov

Dexamethasone and Bupivacaine for Pain After Hernia Surgery

NACompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

January 15, 2023

Conditions

Inguinal Hernia Repair (Not Urgent)

Interventions

DRUG

Bupivacaine + Dexamethasone

20 mg bupivacaine (4 mL of 0.5%) combined with 8 mg dexamethasone, sprayed locally over the mesh and surrounding tissues after placement during laparoscopic TEP hernioplasty.

Trial Locations (1)

06010

Etlik City Hospital (Etlik Şehir Hastanesi), Ankara

All Listed Sponsors

lead

Gürkan Değirmencioğlu

OTHER_GOV

NCT07208253 - Dexamethasone and Bupivacaine for Pain After Hernia Surgery | Biotech Hunter | Biotech Hunter